Tianjin Zhong Xin Pharmaceutical Group Corporation Limited announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was CNY 3,640.421 million compared to CNY 3,290.436 million a year ago. Operating income was CNY 535.115 million compared to CNY 398.293 million a year ago. Net income was CNY 462.548 million compared to CNY 323.462 million a year ago. Basic earnings per share from continuing operations was CNY 0.6 compared to CNY 0.42 a year ago.